FDA deadlines threaten drug safety

被引：0

作者：

不详

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2008年 / 86卷 / 14期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Many drugs are approved against the deadline by FDA which might lead to unintended consequences with regard to drug safety. It is suggested that drug safety might improve under an FDA approval protocol that is more flexible and less driven by deadline pressures.

引用

页码：42 / 42

页数：1

共 50 条

[21] BILL WOULD EMPOWER FDA ON DRUG SAFETY
不详
CHEMICAL & ENGINEERING NEWS, 2010, 88 (32) : 22 - 22
[22] FDA MAY PREEMPT DRUG SAFETY TESTING
不详
MATERIALS RESEARCH AND STANDARDS, 1972, 12 (08): : 34 - &
[23] PatientsLikeMe and FDA collaboration on drug safety data
Reactions Weekly, 2015, 1557 (1) : 5 - 5
[24] The FDA and drug safety - A proposal for sweeping changes
Furberg, Curt D.
Levin, Arthur A.
Gross, Peter A.
Shapiro, Robyn S.
Strom, Brian L.
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (18) : 1938 - 1942
[25] FDA alerts asthmatics to drug safety risk
Ellis, C
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (10) : 765 - 765
[26] FDA proposes changes to ensure drug safety
Wechsler, Jill
FORMULARY, 2007, 42 (03) : 205 - 206
[27] FDA alerts asthmatics to drug safety risk
Clare Ellis
Nature Reviews Drug Discovery, 2003, 2 : 765 - 765
[28] How the FDA Handles GI Drug Safety
Lewis, James H.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (08): : 1264 - 1264
[29] FDA's role in drug safety.
Graham, D.
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S93 - S93
[30] FDA drug labeling for pregnancy and lactation drug safety monitoring systems
Greene, Michael F.
SEMINARS IN PERINATOLOGY, 2015, 39 (07) : 520 - 523

← 1 2 3 4 5 →